Civic AI
Procurement intelligence
Federal contract award
TITLE: BLADDER CANCER CHEMOPREVENTION USING THE ANDROGEN RECEPTOR INHIBITOR APALUTAMIDE
UNIVERSITY OF OKLAHOMA · Department of Health and Human Services
- Value
- $1,435,788
- Start
- Aug 5, 2022
- End
- Feb 4, 2027
- Action date
- Jan 13, 2026
- PIID
- 75N91022F00002
- Status
- active
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- OKLAHOMA CITY, OK
- Award type
- DELIVERY ORDER
Description
TITLE: BLADDER CANCER CHEMOPREVENTION USING THE ANDROGEN RECEPTOR INHIBITOR APALUTAMIDE
Need modifications, related awards, and vendor peers? Open the full award workspace.